The Food and Drug Administration has fined the American Red Cross $16 million for violating blood safety laws and other regulations. Among the problems were mislabeling of blood, failing to record complete information about donors and potential air contamination. The $16 million fine is only the latest penalty assessed against the organization. The FDA has already sent 12 letters to the American Red Cross and imposed over $21 million in fines since 2003. According to the FDA, the Red Cross has taken significant steps to correct the problems.